COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis

Farren Basil Shaw Briggs; Farrah J. Mateen; Hollie Schmidt; Keisha M Currie; Heather M Siefers; Slavka Crouthamel; Bruce F. Bebo; Julie Fiol; Michael K. Racke; Kevin C. O’Connor; Sara Loud; Robert N. McBurney

doi:https://doi.org/10.1212/nxi.0000000000001104

doi.org/10.1212/nxi.0000000000001104

COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis

Farren Basil Shaw Briggs,

Farrah J. Mateen

36

,

..., Robert N. McBurney

25

Neurology: Neuroimmunology & Neuroinflammation8.80

Volume: 9, Issue: 1

Published: Jan 1, 2022

Abstract

BACKGROUND AND OBJECTIVES There are limited data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine reactogenicity in persons with multiple sclerosis (PwMS) and how reactogenicity is affected by disease-modifying therapies (DMTs). The objective of this retrospective cross-sectional study was to generate real-world multiple sclerosis-specific vaccine safety information, particularly in the context of specific DMTs, and...

Paper Fields

Paper Details

Title

COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis

DOI

doi.org/10.1212/nxi.0000000000001104

Published Date

Jan 1, 2022

Journal

Neurology: Neuroimmunology & Neuroinflammation

Volume

9

Issue

1

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History